Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IA14 Induction in Young Acute Myeloid Leukemia
NCT04069208Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idarubicin in acute myeloid leukemia (AML), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
idarubicin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04069208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04069208.